MRC Centre for Molecular Bacteriology and Infection, Imperial College London, Armstrong Road, SW7 2AZ, London, UK.
Curr Top Microbiol Immunol. 2018;416:73-115. doi: 10.1007/82_2018_106.
Two of the enteric Escherichia coli pathotypes-enteropathogenic E. coli (EPEC) and enterohaemorrhagic E. coli (EHEC)-have a conserved type 3 secretion system which is essential for virulence. The T3SS is used to translocate between 25 and 50 bacterial proteins directly into the host cytosol where they manipulate a variety of host cell processes to establish a successful infection. In this chapter, we discuss effectors from EPEC/EHEC in the context of the host proteins and processes that they target-the actin cytoskeleton, small guanosine triphosphatases and innate immune signalling pathways that regulate inflammation and cell death. Many of these translocated proteins have been extensively characterised, which has helped obtain insights into the mechanisms of pathogenesis of these bacteria and also understand the host pathways they target in more detail. With increasing knowledge of the positive and negative regulation of host signalling pathways by different effectors, a future challenge is to investigate how the specific effector repertoire of each strain cooperates over the course of an infection.
两种肠致病性大肠杆菌(EPEC)和肠出血性大肠杆菌(EHEC)具有保守的 III 型分泌系统,这对其毒力至关重要。该 T3SS 用于将 25 至 50 种细菌蛋白直接转运至宿主细胞质中,在那里它们操纵多种宿主细胞过程以建立成功的感染。在本章中,我们将讨论 EPEC/EHEC 的效应蛋白在其靶向的宿主蛋白和过程中的作用——肌动蛋白细胞骨架、小分子鸟苷三磷酸酶和调节炎症和细胞死亡的先天免疫信号通路。这些转运蛋白中的许多已经被广泛研究,这有助于深入了解这些细菌的发病机制,并更详细地了解它们所靶向的宿主途径。随着对不同效应蛋白对宿主信号通路的正调控和负调控的认识不断增加,未来的挑战是研究每个菌株的特定效应蛋白库如何在感染过程中协同作用。